Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19
Joe M. McCord, Brooks M. Hybertson, Adela Cota‐Gomez, Bifeng Gao
Topics & Concepts
Activator (genetics)Carnosic acidTranscription factorBiologyGeneLongevityGene expressionAutophagyBioinformaticsPharmacologyImmunologyGeneticsBiochemistryAntioxidantApoptosisGenomics, phytochemicals, and oxidative stressPhytochemicals and Antioxidant ActivitiesMedicinal Plants and Bioactive Compounds